Relevant bibliographies by topics / Amino acids Metabolism Disorders / Books
To see the other types of publications on this topic, follow the link: Amino acids Metabolism Disorders.

Books on the topic 'Amino acids Metabolism Disorders'

Author: Grafiati
Published: 4 June 2021
Last updated: 28 January 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 books for your research on the topic 'Amino acids Metabolism Disorders.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse books on a wide variety of disciplines and organise your bibliography correctly.

1

Kollegger, Harald. Excitatory amino acids and brain damage. Wien: Facultas-Universitätsverlag, 1993.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Pisters, Peter W. T., 1960- and Brennan Murray F, eds. Protein and amino acid metabolism in cancer cachexia. New York: Chapman & Hall, 1996.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

1918-, Bickel Horst, and Wachtel U, eds. Inherited diseases of amino acid metabolism: Recent progress in the understanding, recognition, and management : international symposium in Heidelberg 1984. Stuttgart ; New York: Thieme, 1985.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

M, Ostrovskiĭ I͡U. Aminokisloty v patogeneze, diagnostike i lechenii alkogolizma. Minsk: Navuka i tėkhnika, 1995.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Jones, Patricia M. Quick guide to organic acid interpretation. Washington D.C: AACC Press, 2011.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Toshihiko, Andō, ed. Aminosan to seikatsu shūkanbyō: Saishin aminoguramu de saguru "inochi" no kagaku = Amino acids. Tōkyō: Joshi Eiyō Daigaku Shuppanbu, 2010.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Parker, James N., and Philip M. Parker. Maple syrup urine disease: A bibliography and dictionary for physicians, patients, and genome researchers [to Internet references]. San Diego, CA: ICON Health Publications, 2007.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Parker, James N., and Philip M. Parker. Beta-ketothiolase deficiency: A bibliography and dictionary for physicians, patients, and genome researchers [to Internet references]. San Diego, CA: ICON Health Publications, 2007.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Parker, James N., and Philip M. Parker. 3-hydroxy-3-methylglutaryl-coenzyme A lyase deficiency: A bibliography and dictionary for physicians, patients, and genome researchers [to internet references]. San Diego, CA: ICON Health Publications, 2007.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Bender, David A. Amino acid metabolism. 3rd ed. Chichester, West Sussex: John Wiley & Sons, 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
11

Amino acid metabolism. 2nd ed. Chichester: Wiley, 1985.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
12

A, Cynober Luc, ed. Amino acid metabolism and therapy in health and nutritional disease. Boca Raton: CRC Press, 1995.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
13

M, Wallsgrove R., and Rothamsted Experimental Station, eds. Amino acids and their derivatives in higher plants. Cambridge [England]: Cambridge University Press, 1995.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
14

D'Mello, J. P. F., ed. The handbook of microbial metabolism of amino acids. Wallingford: CABI, 2017. http://dx.doi.org/10.1079/9781780647234.0000.

Full text
APA, Harvard, Vancouver, ISO, and other styles
15

Masella, Roberta. Glutathione and sulfur amino acids in human health and disease. Hoboken: Wiley, 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
16

Workshop on the Biosynthesis of Branched Chain Amino Acids (1988 Beer-sheva, Israel). Biosynthesis of branched chain amino acids. Weinheim: VCH, 1990.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
17

Rhodes, Jeremy David. The metabolism of sucrose and amino acids by aphids. Norwich: University of East Anglia, 1992.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
18

1940-, Barak Z., Chipman D. M, and Schloss J. V, eds. Biosynthesis of branched chain amino acids: Proceedings of the Workshop on the Biosynthesis of Branched Chain Amino Acids, Beer-sheva, Israel, November 1988. [S.l.]: Balaban Publishers, 1990.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
19

Seymour, Kaufman, G.D. Searle & Co., University of California, Los Angeles., and UCLA Symposium "Amino Acids in Health and Disease: New Perspectives" (1986 : Keystone, Colo.), eds. Amino acids in health and disease: New perspectives : proceedings of a Searle-UCLA symposium held at Keystone, Colorado, May 30-June 4, 1986. New York: Liss, 1987.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
20

Purich, Daniel L. Advances in Enzymology and Related Areas of Molecular Biology, 72: Amino Acid Metabolism. 7th ed. Hoboken: John Wiley & Sons, 1998.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
21

Clinical psycho-oncology: An international perspective. Chichester, West Sussex: John Wiley & Sons, 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
22

Prunty, Helen, Jamie L. Fraser, Charles P. Venditti, and Robin H. Lachmann. Branched Chain Amino Acids. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199972135.003.0016.

Full text
Abstract:
This chapter describes the four most common disorders affecting the degradation of branched chain amino acids: maple syrup urine disease, methylmalonic acidemia, propionic acidemia and isovaleric acidemia. These conditions most commonly present with encephalopathy in the newborn period, although cases with later onset have also been described. Although adult patients are less prone to acute metabolic decompensations, they do develop a number of long-term complications, both neurological and visceral. Management shares features with other disorders of protein metabolism and centers on a low-protein diet and the use of disease-specific amino acid supplements.
APA, Harvard, Vancouver, ISO, and other styles
23

Rovenský, Jozef, Tibor Urbánek, Boldišová Oľga, and James A. Gallagher. Alkaptonuria and Ochronosis. Springer, 2015.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
24

Rovenský, Jozef, Tibor Urbánek, Boldišová Oľga, and James A. Gallagher. Alkaptonuria and Ochronosis. Springer, 2016.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
25

Oľga, Boldisová, Jozef Rovenský, Tibor Urbánek, and James A. Gallagher. Alkaptonuria and Ochronosis. Springer, 2015.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
26

Pisters, Peter W. T., and Murray F. Brennan. Protein and Amino Acid Metabolism in Cancer Cachexia. Springer London, Limited, 2013.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
27

Hartman, Adam L. Amino Acids in the Treatment of Neurological Disorders. Edited by Dominic P. D’Agostino. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780190497996.003.0035.

Full text
Abstract:
Studies of metabolism- and diet-based therapies in epilepsy and neuroprotection have focused primarily on the quality and quantity of fat supplementation or carbohydrate restriction. However, protein is another key dietary component that has not been as thoroughly studied. A number of amino acids have been shown to stop, terminate, or prevent seizures. In addition, some have been shown to exert neuroprotective effects in other neurological disorders. Amino acids (and their metabolites) may exert their effects by acting at membrane or cytoplasmic receptors, serving as substrates for membrane transporters and as modulators of signaling pathway activity. This chapter highlights examples of each of these mechanisms of action in select nervous system disorders.
APA, Harvard, Vancouver, ISO, and other styles
28

Carmel, Ralph, and Donald W. Jacobsen. Homocysteine in Health and Disease. University of Cambridge ESOL Examinations, 2011.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
29

Pearl, Phillip L., and William P. Welch. Pediatric Neurotransmitter Disorders. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199937837.003.0059.

Full text
Abstract:
The pediatric neurotransmitter disorders represent an enlarging group of neurological syndromes characterized by inherited abnormalities of neurotransmitter synthesis, metabolism, and transport. Disorders involving monoamine synthesis include guanosine triphosphate cyclohydrolase deficiency (Segawa disease or classical Dopa-responsive dystonia as the heterozygous form), aromatic amino acid decarboxylase deficiency, tyrosine hydrolase deficiency, sepiapterin reductase deficiency, and disorders of tetrahydrobiopterin synthesis. These disorders can be classified according to whether they feature elevated serum levels of phenylalanine. Disorders of γ-amino butyric acid (GABA) metabolism include succinic semialdehyde dehydrogenase deficiency and GABA-transaminase deficiency. Glycine encephalopathy is typically manifested by refractory neonatal seizures due to a defect in the glycine degradative pathway. Pyridoxine-responsive seizures have now been associated with deficiency of α-aminoadipic semialdehyde dehydrogenase as well as a variants requiring therapy with pyridoxal-5-phosphate and folinic acid.
APA, Harvard, Vancouver, ISO, and other styles
30

Lachmann, Robin, and Elaine Murphy. Aminoacidopathies, urea cycle disorders, and organic acidurias. Edited by Patrick Davey and David Sprigings. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199568741.003.0180.

Full text
Abstract:
Aminoacidopathies are caused by deficiencies in enzymes involved in amino acid metabolism and are often characterized by the accumulation of a toxic amino acid. The two diseases most likely to be encountered in adult medicine are phenylketonuria, which is caused by a deficiency of phenylalanine hydroxylase, and maple syrup urine disease (MSUD), which is due to a branched-chain amino acid decarboxylase deficiency. High levels of phenylalanine progressively damage the developing brain, leading to severe learning difficulties. The high levels of leucine which accumulate in MSUD produce an acute encephalopathy which, if not treated, can rapidly become fatal.
APA, Harvard, Vancouver, ISO, and other styles
31

Rabier, Daniel. Amino Acids. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199972135.003.0083.

Full text
Abstract:
Amino acids present in the different biological fluids belong to two groups: the protein group, with the 21 classical amino acids constituting the backbone of the protein, and the nonprotein group, appearing in different metabolic pathways as intermediate metabolites. It is important to know and to be able to recognize the latter, as they are the markers of many inherited metabolic diseases. Three kinds of pathways must be considered: the catabolic pathways, the synthesis pathways, and the transport pathways. A disorder on a catabolic pathway induces an increase of all metabolites upstream and so an increase of the starting amino acid in all fluids. Any disorder on the synthetic pathway of a particular amino acid will induce a decrease of this amino acid in all fluids. When a transporter is located on a plasma membrane, its deficiency will result in normal or low concentration in plasma concomitant to a high excretion in urine.
APA, Harvard, Vancouver, ISO, and other styles
32

Bender, David A. Amino Acid Metabolism. Wiley & Sons, Incorporated, John, 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
33

Bender, David A. Amino Acid Metabolism. Wiley & Sons, Incorporated, John, 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
34

Bender, David A. Amino Acid Metabolism. Wiley & Sons, Incorporated, John, 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
35

Bender, David A. Amino Acid Metabolism. Wiley & Sons, Limited, John, 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
36

Heales, Simon, Simon Pope, Viruna Neergheen, and Manju Kurian. Abnormalities of CSF Neurotransmitters/Folates. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199972135.003.0082.

Full text
Abstract:
The term Neurotansmitter disorder, in the area of metabolic disease, focuses particularly on inborn errors affecting monoamine (dopamine & serotonin), pyridoxal phosphate (B6) and folate metabolism. Whilst there has been considerable focus on these disorders with regards to the paediatric population, it is clear that an increasing number of adult patients are being identified. Adult neurologists need to be aware of the clinical presentation of such patients and the appropriate tests that need to be requested to ensure a correct diagnosis is achieved. CSF profiling, by a specialist laboratory, is often required. This has the ability to very often identify the nature of a primary defect with regards to implementation of appropriate treatment. For some of these disorders, treatment can be effective. This may be in the form of monoamine/vitamin replacement. However there are exceptions, e.g. aromatic amino acid decarboxylase and dopamine transporter deficiencies. There also needs also to be an awareness of the growing list of secondary factors that can cause impaired dopamine and serotonin metabolism.
APA, Harvard, Vancouver, ISO, and other styles
37

Ahmed, Ahmed I., Sarah Aldhaheri, and Allison Bannick. Inherited Metabolic Diseases (IMDs) and Pregnancy. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190667351.003.0030.

Full text
Abstract:
Inherited metabolic diseases (IMDs) are rare genetic disorders: clinically heterogeneous, and they can present at any age. With the expanded newborn screening panels, many of the IMDs have been successfully screened. Early diagnosis and treatment of these conditions have led to improved neurological outcomes and overall survival of these individuals, and now many of them are reaching childbearing age. Despite treatment, the potential presence of preexisting organ involvement may not only impact their fertility potentials but also may impose a higher risk of adverse maternal and fetal outcomes. Pregnancy leads to an extra strain on maternal metabolism; this may result in the manifestation of symptoms of a previously unknown disease or a progression of a known disease. This chapter will address the possible complications of some inherited disorders of metabolism that are associated with maternal or fetal neurological manifestations such as disorders of energy metabolism (eg, mitochondrial disorders, adult onset urea cycle disorders, ornithine transcarbamylase (OTC) deficiency, amino acidopathies, phenylketonuria (PKU), and impaired fatty acid oxidation disorders). We will provide special emphasis on the available potential treatments and plan of care during pregnancy and postpartum periods.
APA, Harvard, Vancouver, ISO, and other styles
38

Amino Acids in Higher Plants. CABI, 2015.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
39

Khillare, Jayant. Amino Acids in Higher Plants. Scitus Academics LLC, 2015.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
40

Grassi, Luigi, and Michelle Riba. Clinical Psycho-Oncology: An International Perspective. Wiley & Sons, Incorporated, John, 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
41

Grassi, Luigi, and Michelle Riba. Clinical Psycho-Oncology: An International Perspective. Wiley & Sons, Incorporated, John, 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
42

Grassi, Luigi, and Michelle Riba. Clinical Psycho-Oncology: An International Perspective. Wiley & Sons, Incorporated, John, 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
43

Nishikawa, Toru, Tohru Yoshimura, and Hiroshi Homma. D-Amino Acids: Physiology, Metabolism, and Application. Springer, 2018.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
44

Handbook of Microbial Metabolism of Amino Acids. CABI, 2017.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
45

Nishikawa, Toru, Tohru Yoshimura, and Hiroshi Homma. D-Amino Acids: Physiology, Metabolism, and Application. Springer London, Limited, 2016.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
46

Nishikawa, Toru, Tohru Yoshimura, and Hiroshi Homma. D-Amino Acids: Physiology, Metabolism, and Application. Springer, 2016.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
47

Metabolism of Aromatic Amino Acids and Amines. Elsevier, 1987. http://dx.doi.org/10.1016/s0076-6879(00)x0055-9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
48

Kaufman, Seymour, Nathan P. Colowick, and Nathan P. Kaplan. Metabolism of Aromatic Amino Acids and Amines. Elsevier Science & Technology Books, 1987.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
49

Pardee, Joel D., and Suresh Tate. Metabolism of Protein: Fates of Amino Acids. Morgan & Claypool Life Science Publishers, 2011.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
50

Iversen, Leslie L. Amino Acid Neurotransmitters. Springer, 2013.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the bibliographies on the topic 'Amino acids Metabolism Disorders' for other source types:
Journal articles Dissertations / Theses
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography